The Post-Partisan Emporium

  An Illusion of Philanthropy by Hans Vogel Hans Vogel outlines the historical rise of robber barons and their legacy of influence through modern-day globalist philanthropy, showing how charitable foundations and NGOs, guided by the money-driven mindset of their predecessors, now shape international agendas on issues from climate policy to public health. When around 1900 the US economy was  growing  at dizzying rates, a small number of entrepreneurs became extraordinarily successful. That success was measured by a single standard: money. They amassed dazzling amount of dollars. Though none of them was called Scrooge McDuck, they were at least as rich and could swim in coin-filled pools. John Pierpont Morgan, John D. Rockefeller, Cornelius Vanderbilt, Andrew Carnegie, Henry M. Flagler and dozens of tycoons made fortunes so enormous as had hardly ever been seen before. Their fortunes were made in banking, oil, steel, railroads, cotton, chemicals and other branches of trade ...

  The WHO: Building a Permanent Pandemic Market In the face of a potentially industry-ending slew of patent cliffs, Big Pharma has begun acquiring biotechnology companies to stave off collapse. To get these drugs to market, the industry is pursuing the only solution left for their dying model: a full takeover of the WHO to capture the global regulatory system. BY MAX JONES Big Pharma must soon confront an industry-wide hazard that reaches magnitudes far greater than the typical concerns of corporate profit margins and business politics. Through years of industry consolidation, it has essentially made itself “too big to fail.” Only now, the model which it once could never fail within — that is, the practice of obtaining patent exclusivity over drugs that are approved through clinical trials and regulations — has become obsolete, even impossible, under the current conditions of the industry.  In this new climate, the trials and regulations Big Pharma once successfully navigated ...